Christopher T. Chen

801 total citations
30 papers, 507 citations indexed

About

Christopher T. Chen is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Christopher T. Chen has authored 30 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Christopher T. Chen's work include Cancer Genomics and Diagnostics (4 papers), Peptidase Inhibition and Analysis (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Christopher T. Chen is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Peptidase Inhibition and Analysis (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Christopher T. Chen collaborates with scholars based in United States, United Kingdom and France. Christopher T. Chen's co-authors include Gilbert Chan, Aaron S. Kesselheim, Xiaorong Zhang, Madhu M. Bhargava, Peter A. Torzilli, Michael K. Shindle, Frank A. Cordasco, Scott A. Rodeo, Russell F. Warren and Catherine Robertson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christopher T. Chen

27 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher T. Chen United States 11 120 76 75 74 68 30 507
Ana Filipa Mourão Portugal 16 83 0.7× 20 0.3× 145 1.9× 47 0.6× 62 0.9× 58 983
Asgar Ali Kalla South Africa 16 163 1.4× 21 0.3× 122 1.6× 57 0.8× 78 1.1× 42 823
L. Pericleous Canada 10 114 0.9× 68 0.9× 35 0.5× 15 0.2× 33 0.5× 18 328
S.L. Shingler United Kingdom 11 137 1.1× 40 0.5× 31 0.4× 23 0.3× 33 0.5× 18 329
Hasan Tahir United Kingdom 20 92 0.8× 20 0.3× 70 0.9× 24 0.3× 68 1.0× 92 1.5k
Dannette S. Johnson United States 11 34 0.3× 29 0.4× 47 0.6× 22 0.3× 127 1.9× 12 784
Carolina Álvarez United States 14 83 0.7× 14 0.2× 38 0.5× 35 0.5× 49 0.7× 57 483
Kathleen M Ziegler United States 12 122 1.0× 19 0.3× 56 0.7× 93 1.3× 48 0.7× 36 666
A J Silman United Kingdom 15 68 0.6× 20 0.3× 59 0.8× 98 1.3× 59 0.9× 39 1.1k

Countries citing papers authored by Christopher T. Chen

Since Specialization
Citations

This map shows the geographic impact of Christopher T. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Chen more than expected).

Fields of papers citing papers by Christopher T. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Chen. The network helps show where Christopher T. Chen may publish in the future.

Co-authorship network of co-authors of Christopher T. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher T. Chen. A scholar is included among the top collaborators of Christopher T. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher T. Chen. Christopher T. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khanna, Vishesh, Sebastian Fernandez‐Pol, Henning Stehr, et al.. (2024). MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis. 1 indexed citations
2.
Pollom, Erqi L., George A. Fisher, Andrew Shelton, et al.. (2024). Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX).. Journal of Clinical Oncology. 42(16_suppl). 3600–3600. 1 indexed citations
3.
Sharma, Manish, Melissa L. Johnson, Igor Puzanov, et al.. (2024). 758 GLIMMER-01: phase 1/2 trial of a first-in-class bi-sialidase (E-602) in combination with cemiplimab in patients with PD-(L)1-resistant solid tumors. Regular and Young Investigator Award Abstracts. A862–A862. 3 indexed citations
4.
5.
Gilmer, Tona M., Chun-Hsiang Lai, Kathleen A. Ashcraft, et al.. (2024). Abstract LB181: First disclosure of XRD-0394, a novel dual ATM/DNA-PK inhibitor, that potently radiosensitizes and potentiates PARP and topoisomerase inhibitors. Cancer Research. 84(7_Supplement). LB181–LB181. 2 indexed citations
6.
Dumbrava, Ecaterina E., Christopher T. Chen, Gregory M. Coté, et al.. (2023). Abstract B034: A phase 2 basket study of the oral MDM2 inhibitor milademetan for MDM2-amplified advanced solid tumors (MANTRA-2). Molecular Cancer Therapeutics. 22(12_Supplement). B034–B034. 1 indexed citations
7.
Luke, Jason J., Melissa M. Johnson, Anthony W. Tolcher, et al.. (2023). Abstract CT034: GLIMMER-01: initial results from a phase 1 dose escalation trial of a first-in-class bi-sialidase (E-602) in solid tumors. Cancer Research. 83(8_Supplement). CT034–CT034. 6 indexed citations
8.
Chen, Christopher T., Erika Hamilton, Patricia LoRusso, et al.. (2023). 608 Results of a phase 1 study investigating camidanlumab tesirine as monotherapy and in combination with pembrolizumab in patients with selected advanced solid tumors. SHILAP Revista de lepidopterología. A692–A692.
9.
Chen, Christopher T. & James M. Ford. (2022). A Novel Framework for the Next Generation of Precision Oncology Targets. JAMA Oncology. 8(7). 974–974. 2 indexed citations
10.
Leshchiner, Ignaty, Elizabeth E. Martin, Christopher T. Chen, et al.. (2021). Abstract 37: Convergence of resistance patterns in breast cancer after multiple lines of treatment through analysis of rapid autopsy samples. Cancer Research. 81(13_Supplement). 37–37. 1 indexed citations
11.
Duan, Zhijian, Nicolas P. Andrews, Christopher T. Chen, et al.. (2019). Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA‑damaging chemotherapy agents and radiation. Oncology Reports. 43(1). 318–327. 12 indexed citations
12.
Chen, Christopher T., et al.. (2017). Reconstituting Mouse Lungs with Conditionally Reprogrammed Human Bronchial Epithelial Cells. Tissue Engineering Part A. 24(7-8). 559–568. 20 indexed citations
13.
Chen, Christopher T., Ling Li, Gabriel A. Brooks, Michael J. Hassett, & Deborah Schrag. (2017). Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death. Health Services Research. 53(4). 2118–2132. 19 indexed citations
14.
Rutkowski, Joseph M., Johanne Pastor, Kai Sun, et al.. (2016). Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression. Kidney International. 91(2). 324–337. 42 indexed citations
15.
16.
Stoker, Geoffrey E., Jacob M. Buchowski, Christopher T. Chen, et al.. (2013). Hypovitaminosis D and Cervical Disk Herniation among Adults Undergoing Spine Surgery. Global Spine Journal. 3(4). 231–236. 9 indexed citations
17.
Zhang, Xiaorong, Christopher T. Chen, Madhu M. Bhargava, & Peter A. Torzilli. (2012). A Comparative Study of Fibronectin Cleavage by MMP-1, -3, -13, and -14. Cartilage. 3(3). 267–277. 46 indexed citations
18.
Chan, Gilbert & Christopher T. Chen. (2009). Musculoskeletal effects of obesity. Current Opinion in Pediatrics. 21(1). 65–70. 103 indexed citations
19.
Chen, Christopher T., Richard K. Valicenti, Jiandong Lu, et al.. (2001). Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?. International Journal of Radiation Oncology*Biology*Physics. 50(3). 591–595. 31 indexed citations
20.
Chen, Christopher T., Frank M. Waterman, Richard K. Valicenti, et al.. (2001). Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy. International Journal of Cancer. 96(S1). 83–83. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Filipa Mourão Breakdown of academic impact, for papers by Asgar Ali Kalla Breakdown of academic impact, for papers by L. Pericleous Breakdown of academic impact, for papers by S.L. Shingler Breakdown of academic impact, for papers by Hasan Tahir Breakdown of academic impact, for papers by Dannette S. Johnson Breakdown of academic impact, for papers by Carolina Álvarez Breakdown of academic impact, for papers by Kathleen M Ziegler Breakdown of academic impact, for papers by A J Silman
Rankless by CCL
2026